Doctor profile · Federal record
Dr. ALEKSANDRA MAMORSKA-DYGA, M.D.
Hematology & Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · NYACK, NY
- NPI 1467735472
- Accepts Medicare
- 21 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
160 N MIDLAND AVE
NYACK, NY 109601912
(845) 348-2000 - Mailing address
-
7516 86TH RD
WOODHAVEN, NY 114211024
Credentials & registration
- NPI registered
- September 2011 — 15 yrs on file
- Profile last updated
- March 16, 2020
- Year of graduation
- 2005 — 21 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- New York #267944
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1467735472. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,708
Distinct HCPCS
8
Medicare allowed
$215,123
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 733 | 300 | $111 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 545 | 235 | $136 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 206 | 144 | $75 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 109 | 107 | $199 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 72 | 72 | $209 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 16 | 16 | $150 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 15 | 11 | $91 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 12 | 12 | $257 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 291. This provider delivers 5.9× the peer median.Open Payments
Industry payments received
All-time total
$851
Transactions
37
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 6 | $158.16 | |
| Eisai Inc. | 6 | $126.46 | |
| Mirati Therapeutics, Inc. | 4 | $109.57 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $99.53 | |
| PFIZER INC. | 4 | $68.89 | |
| Astellas Pharma US Inc | 2 | $51.20 | |
| Daiichi Sankyo Inc. | 2 | $41.15 | |
| Ipsen Biopharmaceuticals, Inc | 1 | $31.99 | |
| Exelixis Inc. | 2 | $30.68 | |
| Blueprint Medicines Corporation | 1 | $28.87 | |
| PUMA BIOTECHNOLOGY, INC. | 1 | $27.52 | |
| ARRAY BIOPHARMA INC | 1 | $24.33 | |
| Merck Sharp & Dohme LLC | 1 | $22.92 | |
| Janssen Biotech, Inc. | 1 | $15.54 | |
| Myriad Genetic Laboratories, Inc. | 1 | $14.62 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
359
Patients
93
Total drug cost
$131,548
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 114 | 30 | $92,332 |
| Anastrozole | Generic | 101 | 39 | $2,967 |
| Xarelto (Rivaroxaban) | Brand | 31 | 0 | $32,575 |
| Letrozole | Generic | 30 | 13 | $967 |
| Hydroxyurea | Generic | 17 | 0 | $732 |
| Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) | Brand | 16 | 11 | $155 |
| Allopurinol | Generic | 15 | 0 | $240 |
| Enoxaparin Sodium | Generic | 13 | 0 | $1,349 |
| Lidocaine-Prilocaine (Lidocaine/Prilocaine) | Brand | 11 | 0 | $175 |
| Metoprolol Tartrate | Generic | 11 | 0 | $57 |